Finasteride Compounding Legal Status: FDA Approval, Label Details, and Regulatory History
A clinical review of finasteride's FDA approval history, current compounding legal status, official label warnings, and post-market safety surveillance data.
Finasteride: Regulatory History
8 source-based articles maintained by the HealthRX.com Editorial Team.
8articles
4topic areas covered
May 27, 2026latest review
Finasteride: Regulatory History library
Showing 8 of 8 clinical reviews.
Finasteride EMA vs FDA Approach: How Two Regulators Handle the Same Drug Differently
A detailed comparison of how the FDA and EMA regulate finasteride, covering approval history, label warnings, post-market surveillance, and what the procedural divergence means for prescribers and patients.
Finasteride FAERS Safety Signals: What FDA Adverse Event Data Reveal
A clinical review of finasteride safety signals in the FDA Adverse Event Reporting System (FAERS), including sexual dysfunction, depression, and suicidality reports that prompted label revisions.
Finasteride FDA Approval History: Dates, Labels, and Safety Updates
A complete regulatory timeline of finasteride's FDA approval history, covering Proscar (1992), Propecia (1997), generic entry, label changes, and current safety requirements.
Finasteride Global Regulatory Status
A comprehensive review of finasteride's regulatory approvals worldwide, including FDA history, EMA authorization, label updates, post-market safety signals, and current prescribing requirements across major markets.
Finasteride Label Updates 2020 to 2026: What Changed and Why It Matters
A complete breakdown of every FDA label change to finasteride (Propecia, Proscar) from 2020 through 2026, including post-market safety signals, prescriber obligations, and what the updated warnings mean for patients on TRT or hair-loss therapy.
Finasteride Legal & Patent Challenges: FDA Approval, Label History, and Safety Litigation
A comprehensive review of finasteride's FDA approval timeline, patent disputes, generic entry, label evolution, post-market safety signals, and ongoing litigation, with primary-source citations throughout.
Finasteride Pipeline and Next-Gen: FDA History, Label Changes, and What's Coming
A full regulatory history of finasteride, including FDA approval dates, Black Box label changes, post-market surveillance findings, and next-generation 5-ARI alternatives in development.